Zynex, inc. (zyxi) shares under pressure amid tricare payment halt, dim outlook, and investor lawsuit – hagens berman

San francisco, april 14, 2025 (globe newswire) -- shares of zynex inc. (nasdaq: zyxi), a medical device manufacturer specializing in nerve stimulation products, are trading down 65% over the past month, as the company grapples with a confluence of financial setbacks, regulatory scrutiny, and a pending investor class action. hagens berman is investigating claims for alleged violations of the u.s. securities laws and urges investors who purchased zynex securities and suffered substantial losses to submit your losses now.
ZYXI Ratings Summary
ZYXI Quant Ranking